Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 32283159)

Published in J Infect on April 11, 2020

Authors

Zeming Liu1, Wei Long1, Mengqi Tu2, Sichao Chen1, Yihui Huang1, Shipei Wang1, Wei Zhou1, Danyang Chen1, Ling Zhou1, Min Wang1, Meng Wu3, Qi Huang4, Haibo Xu5, Wen Zeng6, Liang Guo7

Author Affiliations

1: Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
2: Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
3: Department of Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
4: Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
5: Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: 714380246@qq.com.
6: Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: 524578732@qq.com.
7: Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: guoliangwhzn@163.com.

Articles citing this

CD4+T, CD8+T counts and severe COVID-19: A meta-analysis. J Infect (2020) 0.75

Articles cited by this

Clinical progression of patients with COVID-19 in Shanghai, China. J Infect (2020) 6.61